![Blair Jackson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Blair Jackson
Verksamhetschef på
ALKERMES PLC
Förmögenhet: 10 M $ per 2026-05-31
Profil
Blair C.
Jackson currently works at Rodin Therapeutics, Inc., as Chairman & President, Synchronicity Pharma, Inc., as Director from 2018, Alkermes Pharma Ireland Ltd., as Director, and Alkermes Plc, as Chief Operating Officer & Executive Vice President from 2025.
Mr. Jackson also formerly worked at Civitas Therapeutics, Inc., as Director from 2010 to 2015 and Alkermes, Inc., as Senior Vice President-Corporate Planning from 2018 to 2021.
Mr. Jackson received his graduate degree from Massachusetts Institute of Technology, undergraduate degree and Masters Business Admin degree from the University of Alberta, and undergraduate degree from the University of Calgary.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-13 | 241 308 ( 0,14 % ) | 10 M $ | 2026-05-31 |
Aktiva positioner av Blair Jackson
| Företag | Position | Start |
|---|---|---|
| ALKERMES PLC | Verksamhetschef | 2021-01-11 |
Alkermes Pharma Ireland Ltd.
 Alkermes Pharma Ireland Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures oral dosage products | Direktör/Styrelseledamot | - |
Synchronicity Pharma, Inc.
 Synchronicity Pharma, Inc. Pharmaceuticals: OtherHealth Technology Discovers, develops and commercializes novel therapeutics | Direktör/Styrelseledamot | 2018-10-01 |
Rodin Therapeutics, Inc.
 Rodin Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological disorders | Ordförande | - |
Tidigare kända positioner av Blair Jackson
| Företag | Position | Slut |
|---|---|---|
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Företagsledare/Principal | 2021-01-01 |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Direktör/Styrelseledamot | 2015-01-01 |
Blair Jacksons utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
60
Första gradens relationer
9
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of Alberta
 University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Calgary
 University of Calgary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synchronicity Pharma, Inc.
Synchronicity Pharma, Inc. Pharmaceuticals: OtherHealth Technology Discovers, develops and commercializes novel therapeutics | Health Technology |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Health Technology |
Alkermes Plc
 Alkermes Plc Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products to treat neurodegenerative disorders and cancer | Health Technology |
Alkermes Pharma Ireland Ltd.
Alkermes Pharma Ireland Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures oral dosage products | Health Technology |
Rodin Therapeutics, Inc.
Rodin Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological disorders | Health Technology |
